These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31923313)

  • 21. [Vasodilators and diuretics, basic therapy for hypertensive heart failure (author's transl)].
    Bühler FR; Amann FW
    Schweiz Rundsch Med Prax; 1979 Aug; 68(33):1049-52. PubMed ID: 38450
    [No Abstract]   [Full Text] [Related]  

  • 22. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C; Bohn DJ; Freedom RM; Rabinovitch M
    Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral vasodilators in the treatment of cardiac failure.
    Forrester JS; da Luz PL
    Adv Cardiol; 1976; 17():123-32. PubMed ID: 818884
    [No Abstract]   [Full Text] [Related]  

  • 24. Afterload reduction in the treatment of cardiac failure.
    Mason DT
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1695-703. PubMed ID: 102028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical response to the vasodilators.
    Gould L; Patel S; Gomes GI; Reddy CV
    Angiology; 1982 Feb; 33(2):125-30. PubMed ID: 7065456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of vasodilators in the treatment of congestive heart failure and myocardial ischaemia (author's transl)].
    Tarnow J
    Anaesthesist; 1981 Jun; 30(6):269-79. PubMed ID: 6791517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood Pressure Reduction in Hypertensive Acute Heart Failure.
    Harrison N; Pang P; Collins S; Levy P
    Curr Hypertens Rep; 2021 Feb; 23(2):11. PubMed ID: 33611627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study.
    Kommireddy S; Bhyravavajhala S; Kurimeti K; Chennareddy S; Kanchinadham S; Rajendra Vara Prasad I; Rajasekhar L
    Rheumatology (Oxford); 2015 Sep; 54(9):1673-9. PubMed ID: 25929760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of benefit of preload reduction in coronary heart disease].
    Simon H
    Med Klin (Munich); 1987 Jan; 1():6-9. PubMed ID: 3472031
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of cardiac insufficiency with vasodilators].
    Salazar Dávila E
    Cardiology; 1980; 66 Suppl 2():146-53. PubMed ID: 7285025
    [No Abstract]   [Full Text] [Related]  

  • 31. [The prevalently arterial vasodilators].
    Camerini F; Klugmann S; Borgioni L; Salvi A
    G Ital Cardiol; 1979; 9 Suppl 1():20-2. PubMed ID: 548301
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial: Reducing the work load of the failing heart.
    Vaisrub S
    JAMA; 1973 Dec; 226(11):1350-1. PubMed ID: 4800763
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiac failure XIV. Treatment by modification of circulatory dynamics.
    Cohn JN
    Hosp Pract (Off Ed); 1984 Aug; 19(8):37-52. PubMed ID: 6430933
    [No Abstract]   [Full Text] [Related]  

  • 34. Vasodilator therapy for heart failure. Concepts, applications, and challenges.
    Rubin SA; Swan HJ
    JAMA; 1981 Feb; 245(7):761-3. PubMed ID: 7463665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vasodilators in "primary" pulmonary hypertension?].
    Morpurgo M
    G Ital Cardiol; 1990 Feb; 20(2):123-25. PubMed ID: 2328865
    [No Abstract]   [Full Text] [Related]  

  • 36. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRO: vasodilators remain an indispensable treatment for acute heart failure.
    Vanhentenrijk S; Verbrugge FH; Tang WHW; Menon V
    Eur Heart J Acute Cardiovasc Care; 2022 Nov; 11(11):850-857. PubMed ID: 36208185
    [No Abstract]   [Full Text] [Related]  

  • 38. Congestive heart failure: pathophysiology and management with special reference to systemic hypertension.
    Visser FC
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S8-11. PubMed ID: 1721986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vasodilator therapy in cardiology].
    Cárdenas Loaeza M
    Cardiology; 1980; 66 Suppl 2():1-6. PubMed ID: 6116540
    [No Abstract]   [Full Text] [Related]  

  • 40. [Peripheral vasodilators in the treatment of heart failure].
    Ol'binskaia LI
    Farmakol Toksikol; 1989; 52(2):116-22. PubMed ID: 2744139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.